1,830
Views
3
CrossRef citations to date
0
Altmetric
Review

Management of acute asthma exacerbations in children

Pages 607-616 | Published online: 09 Jan 2014

References

  • McCaig LF. National Hospital Ambulatory Medical Care Survey: 1992. Emergency department summary. Adv. Data2(245), 1–12 (1994).
  • Stein LM, Cole RP. Early administration of corticosteroids in emergency room treatment of acute asthma. Arch. Intern. Med.112, 822–827 (1990).
  • Rowe BH, Bota GW, Pollack CV, Emond SD, Camargo CA. Management of acute asthma among adults presenting to Canadian versus US emergency departments. Ann. Emerg. Med.32(3 Pt 2), S2–S3 (1998).
  • Chapman KR, Verbeek PR, White JG, Rebuck AS. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N. Engl. J. Med.324, 788–794 (1991).
  • Hilton S, Sibbald B, Anderson HR, Freeling P. Controlled evaluation of the effects of patient education on asthma morbidity in general practice. Lancet1(8471), 26–29 (1986)
  • GINA. Pocket guide for asthma management and prevention. The Global Initiative for Asthma (GINA) 18 (2006).
  • Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin. Pediatr.40, 79–86 (2001).
  • Volovitz B, Soferman R, Blau H, Nussinovitch M, Varsano I. Rapid induction of clinical response with a short-term high-dose starting-schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J. Allergy Clin. Immunol.101, 464–469 (1998).
  • Volovitz B, Bilavsky E, Nussinovitch M. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. J. Asthma45, 561–567 (2008).
  • DeNicola LK Monem GF, O’Gayle M, Kisson N. The treatment of critical status asthmaticus in children. Pediatr. Clin. North Am.41, 1293–1324 (1994).
  • Alario AJ, Lewander WJ, Dennehy P, Seiffer R, Mansell AL. The relationship between oxygen saturation and the clinical assessment of acutely wheezing infants and children. Pediatr. Emerg. Care11, 331–334 (1995).
  • Gleeson JG, Green S, Price JF. Air or oxygen as driving gas for nebulised salbutamol. Arch. Dis. Child.63(8), 900–904 (1988).
  • Geelhoed GC, Landau LI, Le Souef PN, Evaluation of SaO2 as predictor of outcome in 280 children presenting with acute asthma. Ann. Emerg. Med.23, 1236–1241 (1994).
  • Geelhoed GC, Landau LI, LeSoef PN. Predictive value of oxygen saturation in emergency evaluation of asthmatic children. Br. Med. J.297(6645), 395–396 (1988).
  • Bateman ED, Hurd SS, Barnes PJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J.31, 143–178 (2008).
  • Poets CF, Stebbens VA, Samuels MP, Southall DP. Oxygen saturation and breathing patterns in children. Pediatrics92, 686–690 (1993).
  • Svedmyr N. A β2-adrenergic agonist for use in asthma: pharmacology, pharmacokinetics clinical efficacy and adverse effects. Pharmacotherapy5, 109–126 (1985).
  • British Thoracic Society. Guidelines on the management of asthma. Thorax48, S1–S24 (1993).
  • Newhouse MT. Are nebulizers obsolete for administering asthma medications to infants and children? Pediatr. Pulmonol.15(5), 271–272 (1993).
  • Kerem E, Levison H, Schuh S et al. Efficacy of albuterol administered by nebulizers versus spacer device in children with acute asthma. J. Pediatr.123(2), 313–317(1993).
  • Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulizer for β-agonist treatment of acute asthma. Cochrane Database Syst. Rev.2, CD000052 (2006).
  • Parkin PC, Saunders NR, Diamond SA, Winders PM, Macarthur C. Randomised trial spacer versus nebulizer for acute asthma Arch. Dis. Child.72(3), 239–240 (1995).
  • Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers vs. nebulizers for pediatric asthma. Arch. Pediatr. Adolesc. Med.149, 201–205 (1995).
  • Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost saving in a large acute-care hospital. Chest101, 305–308 (1992).
  • Volovitz B, Bentur L, Finkelstein Y et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J. Allergy Clin. Immunol.102, 605–609 (1998).
  • Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program, National Heart Lung and Blood Institute 29 August (2007).
  • Browne GJ, Penna AS, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet349(9048), 301–305 (1997).
  • Barnes PJ. β adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med.152, 838–860 (1995).
  • Portnoy J, Nadel G, Amado M, Willsee-Edigar S. Continuous nebulization for status asthmaticus. Ann. Allergy69(1), 71–79 (1992).
  • Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and β2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst. Rev.4, CD000060 (2000).
  • Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch. Dis. Child.90(1), 74–77 (2005).
  • Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst. Rev.1, CD002178 (2001).
  • Fiel SB, Vincken W. Systemic corticosteroid therapy for acute asthma exacerbations. J. Asthma43(5), 321–331(2006).
  • Rachelefsky G. Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics112(2), 382–397 (2003).
  • Lapin CD, Cloutier MM. Outpatient management of acute exacerbations of asthma in children. J. Asthma32(1), 5–20 (1995).
  • Tal A, Levy N, Bearman JE. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics86(3), 350–356 (1990).
  • Barnett PL, Caputo GL, Baskin M, Kuppermann N. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann. Emerg. Med.29(2), 212–217 (1997).
  • Hodsman AB, Toogood JH, Jennings B, Fraher LJ, Baskerville JC. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J. Clin. Endocrinol. Metab.72, 530–540 (1991).
  • Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr. Pulmonol.16, 341–346 (1993).
  • Hedlin G, Svedmyr J, Ryden A-C. Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma. Acta Paediatr.88, 48–51 (1999).
  • Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin. Pharmacol. Ther.13, 694–702 (1972).
  • Zora JA, Zimmerman D, Carey TL. Hypothalamic–pituitary–adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J. Allergy Clin. Immunol.77, 9–13 (1986).
  • Hendeles L. Selecting a systemic corticosteroid for acute asthma in young children. J. Pediatr.142(Suppl. 2), S40–S44 (2003).
  • Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest130(5), 1301–1311 (2006).
  • Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir. Med.101(4), 685–695 (2007).
  • Rodrigo GJ. Inhaled corticosteroids in the treatment of asthma exacerbations: essential concepts. Arch. Bronconeumol.42, 533–540 (2006).
  • Garrett J, Williams S, Wong C, Holdaway D. Application of asthma action plan to childhood asthma: a national survey. NZ Med. J.110, 308–310 (1997).
  • Barnes PJ. Inhaled glucocorticoids for asthma. N. Engl. J. Med.332, 868–875 (1995).
  • Hodsman AB, Toogood JH, Jennings B, Fraher LJ, Baskerville JC. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J. Clin. Endocrinol. Metab.72, 530–540 (1991).
  • Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr. Pulmonol.16, 341–346 (1993).
  • Hedlin G, Svedmyr J, Ryden AC. Systemic effects of a short course of betamethasone compared with high-dose inhaled budesonide in early childhood asthma. Acta Paediatr.88, 48–51 (1999).
  • Rodrigo GJ. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am. J. Respir. Crit. Care Med.171, 1231–1236 (2005).
  • Scarfone RJ, Loiselle JM, Wiley JF 2nd, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann. Emerg. Med.26, 480–486 (1995).
  • Lin RY, Newman TG, Sauter D et al. Association between reported use of inhaled triamcinolone and differential short-term responses to aerosolized albuterol in asthmatics in an emergency department setting. Chest106, 452–457 (1994).
  • Volovitz B, Kauschansky A, Nussinovitch M, Harel I, Varsano I. Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide. J. Allergy Clin. Immunol.96, 874–878 (1995).
  • Volovitz B, Amir J, Malik H, Kaushansky A, Varsano I. Growth and pituitary–adrenal function in children with severe asthma treated with inhaled budesonide. N. Engl. J. Med.329, 1703–1738 (1993).
  • De Benedictis FM, Del Giudice MM, Vetrella M et al. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. J. Asthma42(5), 331–336 (2005).
  • Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur. Respir. J.27, 172–187 (2006).
  • Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N. Engl. J. Med.353, 1711–1723 (2005).
  • Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur. Respir. J.21, 989–993 (2003).
  • Urbach V, Walsh DE, Mainprice B, Bousquet J, Harvey BJ. Rapid non-genomic inhibition of ATP-induced CL-secretion by dexamethasone in human bronchial epithelium. J. Physiol.543, 869–878 (2002).
  • Schuh S, Reisman J, Alshehri M et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N. Engl. J. Med.343, 689–694 (2000).
  • Schuh S, Dick PT, Stephens D et al. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics118(2), 644–665 (2006).
  • Edmonds ML, Camargo CA Jr, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Cochrane review). In: The Cochrane Library (Version 4). Oxford: Update Software (2003).
  • McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood (Cochrane review). In: The Cochrane Library (Version 4) Oxford, Update Software (2000).
  • Singhi S, Banerjee S, Nanjundaswamy H. Inhaled budesonide in acute asthma. J. Paediatr. Child Health35, 483–487 (1999).
  • Devidayal Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared with oral prednisolone in acute bronchial asthma. Acta Paediatr.88, 835–840 (1999).
  • Matthews EE, Curtis PD, McLain BI, Morris LS, Turbitt ML. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta Paediatr.88, 841–843 (1999).
  • Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir. Med.94, 1206–1214 (2000).
  • Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am. J. Respir. Crit. Care Med.157, 698–703 (1998).
  • Sung L, Osmond MH, Klassen TP. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad. Emerg. Med.5, 209–213 (1998).
  • Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch. Dis. Child.68, 85–87 (1993).
  • Svedmyr J, Nyberg E, Thunqvist P, Asbrink-Nilsson E, Hedlin G. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections. Acta Paediatr.84, 884–888 (1995).
  • Svedmyr J, Nyberg E, Asbrink-Nilsson E, Hedlin G. Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers. Acta Paediatr.88, 42–47 (1999).
  • Volovitz B, Nussinovitch M. Management of children with severe asthma exacerbation in the emergency department. Paediatr. Drugs4, 141–148 (2002).
  • Varsano I, Volovitz B, Malik H, Amir Y. Safety of one year treatment with budesonide in young children with asthma. J. Allergy Clin. Immunol.5, 914–920 (1990).
  • Garrett J, Williams S, Wong C, Holdaway D. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch. Dis. Child.79, 12–17 (1998).
  • Volovitz B, Shkap R, Amir J, Calderon S, Varsano I, Nussinovitch M. Absence of tooth staining with doxycycline treatment in young children. Clin. Pediatr. (Phila.)46(2), 121–126 (2007).
  • Lieberman D, Lieberman D, Printz S et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am. J. Respir. Crit. Care Med.167, 406–410 (2003).
  • Hahn DL, Bukstein D, Luskin A, Zeitz H. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann. Allergy. Asthma Immunol.80(1), 45–49 (1998).
  • Amsden GW. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J. Antimicrob. Chemother.55(1), 10–21 (2005).
  • Esposito S, Principi N. Asthma in children: are Chlamydia or Mycoplasma involved? Paediatr. Drugs3(3), 159–168 (2001).
  • Daian CM, Wolff AH, Bielory L. The role of atypical organisms in asthma. Allergy Asthma Proc.21, 107–111 (2000).
  • Ferrara G, Losi M, Franco F, Corbetta L, Fabbri M, Richeldi L. Macrolides in the treatment of asthma and cystic fibrosis. Respir. Med.99(1), 1–10 (2005).
  • Harmanci K, Bakirtas A, Turktas I, Degim T. Oral montelukast treatment of preschool-aged children with acute asthma. Ann. Allergy Asthma Immunol.96(5), 731–735 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.